Literature DB >> 35062028

The Frequency of Focal Cortical Dysplasia-Like Histologic Features Near Adult-Type Diffuse Gliomas.

Mireille Bitar1, Yevgen Chornenkyy1, Margaret E Flanagan1,2, Alicia Steffens3, Kathleen McCortney1,3, Craig Horbinski1,2.   

Abstract

While the coexistence of focal cortical dysplasia (FCD) and grade 1 noninfiltrative gliomas has been described, to date, only rare case reports have described FCD adjacent to infiltrating gliomas. We therefore sought to determine how often FCD-like findings occur near adult-type diffuse gliomas. This was a retrospective survey of 186 consecutive, newly diagnosed, en bloc glioma resections. Fifty-nine (31.7%) had sufficient adjacent cortex to evaluate for FCD-like features. Among IDH mutant ("IDHmut") gliomas, 40/77 (52%) had adjacent evaluable cortex, whereas only 19/109 (17%) of IDH wild-type ("IDHwt") gliomas did (p < 0.0001). Among cases with evaluable cortex, 15 (25.4%) contained features suggestive of FCD, including radial/tangential dyslamination and/or maloriented neurons. In a multivariable analysis, increasing glioma grade (OR = 4.0, 95% CI = 1.2-13.5, p = 0.027) and IDHmut (OR = 6.5, 95% CI = 1.3-32.2, p = 0.022) emerged as independently positive correlates with the appearance of FCD-like findings. However, FCD-like features were also found in 13/32 (40.6%) cortical samples from adult brains without any neoplastic disease or seizure histories (p = 0.16). Together, these data suggest that, while FCD-like histologic features can be incidentally found in at least a subset of diffusely infiltrative gliomas, the frequencies are not significantly different from that seen in otherwise non-neoplastic brains, and are therefore most likely nonpathologic.
© 2021 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Focal cortical dysplasia; Glioma

Mesh:

Year:  2022        PMID: 35062028      PMCID: PMC8782601          DOI: 10.1093/jnen/nlab120

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

1.  Intrinsic epileptogenicity of gangliogliomas may be independent from co-occurring focal cortical dysplasia.

Authors:  Carmen Barba; Roland Coras; Flavio Giordano; Anna Maria Buccoliero; Lorenzo Genitori; Ingmar Blümcke; Renzo Guerrini
Journal:  Epilepsy Res       Date:  2011-08-09       Impact factor: 3.045

2.  Pleomorphic xanthoastrocytoma associated with long-standing Taylor-type IIB-focal cortical dysplasia in an adult.

Authors:  Bomi Kim; Chun-Kee Chung; Jae Kyung Myung; Sung-Hye Park
Journal:  Pathol Res Pract       Date:  2008-07-26       Impact factor: 3.250

3.  Focal cortical dysplasia coexisting with diffuse astrocytoma in childhood: a case report and reappraisal of the glial component in archival FCD cases.

Authors:  Kenta Masui; Satoshi O Suzuki; Kimiaki Hashiguchi; Takato Morioka; Takashi Yoshiura; Tomio Sasaki; Toru Iwaki
Journal:  Neuropathology       Date:  2010-12-01       Impact factor: 1.906

Review 4.  Review: The international consensus classification of Focal Cortical Dysplasia - a critical update 2018.

Authors:  I M Najm; H B Sarnat; I Blümcke
Journal:  Neuropathol Appl Neurobiol       Date:  2018-02       Impact factor: 8.090

5.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

Review 6.  The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Authors:  Craig Horbinski; Keith L Ligon; Priscilla Brastianos; Jason T Huse; Monica Venere; Susan Chang; Jan Buckner; Timothy Cloughesy; Robert B Jenkins; Caterina Giannini; Roger Stupp; L Burt Nabors; Patrick Y Wen; Kenneth J Aldape; Rimas V Lukas; Evanthia Galanis; Charles G Eberhart; Daniel J Brat; Jann N Sarkaria
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

7.  Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors. A report of three cases.

Authors:  B Lach; N Duggal; V F DaSilva; B G Benoit
Journal:  Cancer       Date:  1996-12-15       Impact factor: 6.860

8.  Outcome of epilepsy surgery in focal cortical dysplasia.

Authors:  T Kral; H Clusmann; I Blümcke; R Fimmers; B Ostertun; M Kurthen; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

9.  Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures.

Authors:  R A Prayson; M L Estes; H H Morris
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

10.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.

Authors:  Quinn T Ostrom; Nirav Patil; Gino Cioffi; Kristin Waite; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2020-10-30       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.